2024    2023    2022    2021    2020    2019    2018    2017    2016   

2020

Articles

91 - 

Is the COVID-19 Pandemic a Good Time to Include Aspergillus Molecular Detection to Categorize Aspergillosis in ICU Patients? A Monocentric Experience

J-P Gangneux, Florian Reizine, Hélène Guegan, Kieran Pinceaux, Pierre Le Balch et al.

Journal of Fungi, 2020, 6 (3), pp.105.

DOI : https://doi.org/10.3390/jof6030105

Pubmed : 32664423

 

92 - 

Invasive fungal diseases during COVID-19: We should be prepared

J-P Gangneux, M-E Bougnoux, E Dannaoui, M Cornet, J R Zahar et al.

Journal of Medical Mycology = Journal de Mycologie Médicale, 2020, 30 (2), pp.100971.

DOI : https://doi.org/10.1016/j.mycmed.2020.100971

Pubmed : 32307254

 

93 - 

Metagenomic Characterization of Indoor Dust Bacterial and Fungal Microbiota in Homes of Asthma and Non-asthma Patients Using Next Generation Sequencing

J-P Gangneux, Mohamed Sassi, Pierre Lemire, Pierre Le Cann

Frontiers in Microbiology, 2020, 11, pp.1671.

DOI : https://doi.org/10.3389/fmicb.2020.01671

Pubmed : 32849345

 

94 - 

Outcomes of Antifungal Prophylaxis in High-Risk Haematological Patients (AML under Intensive Chemotherapy): The SAPHIR Prospective Multicentre Study

J.-P. Gangneux, Christophe Padoin, Mauricette Michallet, Emeline Saillio, Alexandra Kumichel et al.

Journal of Fungi, 2020, 6 (4), pp.281.

DOI : https://doi.org/10.3390/jof6040281

Pubmed : 33198192

 

95 - 

Asthma and Indoor Environment Usefulness of a Global Allergen Avoidance Method on Asthma Control and Exposure to Molds

Jean-Pierre Gangneux, Matthieu Bouvrais, Sophie Frain, Hugues Morel, Séverine Deguen et al.

Mycopathologia, 2020, 185 (2), pp.367-371.

DOI : https://doi.org/10.1007/s11046-019-00417-9

Pubmed : 31897973

 

96 - 

Exposure to glycol ethers among 6-year-old children in France

Ronan Garlantézec, C. Warembourg, F. Le Gléau, C. Montfort, F. Rouget et al.

International Journal of Hygiene and Environmental Health, 2020, 227, pp.113510.

DOI : https://doi.org/10.1016/j.ijheh.2020.113510

Pubmed : 32172156

 

97 - 

Phenoxyethanol, reproduction and development: additional studies are needed

Ronan Garlantézec, C. Warembourg, R. Beranger, Cécile Chevrier

Journal of the European Academy of Dermatology and Venereology, 2020, 34 (8),

DOI : https://doi.org/10.1111/jdv.16344

Pubmed : 32145107

 

98 - 

A Lateral Flow Immunoassay test performance in SARS-CoV-2 seroprevalence surveys: a validation study among healthcare workers

Ronan Garlantézec, Christopher Heslan, Emilie Tadie, Pierre Tattevin, V. Thibault et al.

Emerging Microbes and Infections, 2020, 9 (1), pp.2547-2549.

DOI : https://doi.org/10.1080/22221751.2020.1852893

Pubmed : 33206004

 

99 - 

Toxoplasma gondii-specific IgG avidity testing in pregnant women

Cécile Garnaud, Hélène Fricker-Hidalgo, Birgitta Evengård, Míriam J Álvarez-Martinez, Eskild Petersen et al.

Clinical Microbiology and Infection, 2020, 26 (9), pp.1155-1160.

DOI : https://doi.org/10.1016/j.cmi.2020.04.014

Pubmed : 32334096

 

100 - 

Dépistage, prise en charge et suivi des personnes potentiellement surexposées à l’arsenic inorganique du fait de leur lieu de résidence [Screening, diagnosis, treatment and follow-up of people suspected to be overexposed to inorganic arsenic due to their place of residence]

R. Garnier, E. Nouyrigat, P. Benoit, J.-P. Goullé, C. Granon et al.

Dépistage, prise en charge et suivi des personnes potentiellement surexposées à l’arsenic inorganique du fait de leur lieu de résidence. Archives des Maladies Professionnelles et de L'Environnement, 2020, 81 (6), pp.770-796.

DOI : https://doi.org/10.1016/j.admp.2020.06.004